With Aimco, Fitzsimons Innovation Community hosted members of the local and media to learn firsthand about breakthrough work from 10 of the 80+ visionary biotech and life sciences companies in the Fitzsimons Innovation Community ecosystem who are defining the future of health and care.
Find out what's happening on campus and across the industry.
Read Fitzsimons Innovation Community news, industry highlights, editorials, and innovation updates happening weekly on our campus.
European Medicines Agency (EMA) Validates Atara Biotherapeutics' Marketing Authorization Application
Atara Biotherapeutics announced that the Marketing Authorization Application (MAA) for tabelecleucel (tab-cel®) has been fully validated by the European Medicines Agency (EMA).
Expertscape rankings recognize Richard Schulick, MD, and Marco Del Chiaro, MD, among the top 0.1% of scholars worldwide.
Taiga Initiates Phase 1/2 Clinical Study of TBX-2400 in Acute Myeloid Leukemia and Myelofibrosis in Croatia
TBX-2400 is expected to improve engraftment and reconstitution of immune system for patients receiving Hematopoietic Stem Cell Transplants.